Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Neurotrophic Keratitis > Corneal neurotization shows sustained improvements in sensation and disease stage in neurotrophic keratopathy
  • Neurotrophic Keratitis

Corneal neurotization shows sustained improvements in sensation and disease stage in neurotrophic keratopathy

Ophthalmology 360

Key Takeaways

  1. Corneal neurotization was associated with significant long-term improvements in corneal sensation and neurotrophic keratopathy severity.
  2. Visual acuity remained stable over follow-up, and complications were uncommon and non–vision-threatening.
  3. Younger patients and those with peripheral etiologies showed greater postoperative improvement.

Corneal neurotization (CN) is associated with sustained improvements in corneal sensation and disease severity in patients with neurotrophic keratopathy over long-term follow-up, according to a study.

The analysis included 58 eyes from 58 patients who underwent CN between 2016 and 2024 at Duke University Hospital and the Leyngold Institute for Plastic Surgery, all performed by a single surgeon.

Demographic data and clinical measures were assessed at 6–12 months postoperatively, and at the last follow-up visit of at least 12 months. Median follow-up was 30 months.

There were significant improvements in Mackie stage and corneal sensation at both postoperative time points compared with baseline. Best-corrected visual acuity did not significantly change over time. Greater improvement was observed in younger patients and in those with peripheral, rather than central, neurotrophic keratopathy etiologies. Use of cenegermin was not associated with significant differences in outcomes.

Complications, which were not vision-threatening or disfiguring, were reported in 4 patients. Among patients who required additional ocular surface rehabilitative procedures after CN, 82% tolerated these surgeries without corneal decompensation.

Reference
Robbins JO, Okrent AL, Grigore E, et al. Long-term outcomes of corneal neurotization for neurotrophic keratopathy: a dual center, single surgeon retrospective study. Plast Reconstr Surg. 2025;doi: 10.1097/PRS.0000000000012743. Epub ahead of print. PMID: 41428966.

Share

Related Content

  • Neurotrophic Keratitis

Cenegermin improves corneal healing in moderate to severe neurotrophic keratitis

  • Neurotrophic Keratitis

Shelf-stable amniotic membrane improved outcomes in early-stage neurotrophic keratopathy

  • Conference Roundup

Cryopreserved amniotic membrane significantly improves ocular surface integrity in patients with severe keratoconjunctivitis sicca and neurotrophic keratopathy

  • Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

  • Neurotrophic Keratitis

Early detection and targeted treatment strategies are critical for optimal outcomes in neurotrophic keratitis

  • Neurotrophic Keratitis

Amniotic membrane improves severe autoimmune-related KCS and NK outcomes

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon